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Abstract 
Background: The advent and use of highly sensitive molecular biology techniques to explore the microbiota and 
microbiome in environmental and tissue samples have detected the presence of contaminating microbial DNA within 
reagents. These microbial DNA contaminants may distort taxonomic distributions and relative frequencies in micro-
bial datasets, as well as contribute to erroneous interpretations and identifications.
Results: We herein report on the occurrence of bacterial DNA contamination within commonly used DNA extrac-
tion kits and PCR reagents and the effect of these contaminates on data interpretation. When compared to previ-
ous reports, we identified an additional 88 bacterial genera as potential contaminants of molecular biology grade 
reagents, bringing the total number of known contaminating microbes to 181 genera. Many of the contaminants 
detected are considered normal inhabitants of the human gastrointestinal tract and the environment and are often 
indistinguishable from those genuinely present in the sample.
Conclusions: Laboratories working on bacterial populations need to define contaminants present in all extraction 
kits and reagents used in the processing of DNA. Any unusual and/or unexpected findings need to be viewed as pos-
sible contamination as opposed to unique findings.
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Background
Microbes are the predominant life form on earth and 
probably have been the since prokaryotic life began on 
earth some 3.5 billion years ago [1, 2]. Since DNA may 
persist for thousands of years, it is not surprising that evi-
dence of bacterial existence (bacterial DNA) can be found 
in almost all ecosystems. This has become more evident 
with the advent of highly sensitive molecular techniques, 
such as PCR, 16S rRNA gene and metagenomic shotgun 
sequencing methods, capable of identifying hosts of cul-
tivable and uncultivable microorganisms. By the use of 
these methods, it has long been realized that molecular 
biology grade (MBG) reagents, DNA isolation kits, PCR 
master mixes, and several other laboratory supplies used 
in processing and analyses of DNA are contaminated with 
bacterial DNA [3–7]. Although microbial contamination 
from exogenous and endogenous sources is a constant 
worry of microbiologists, it is often less of a concern for 
molecular biologists who erroneously assume that MBG 
reagents are free of microbial DNA. As such, the poten-
tial impact of microbial contamination by MBG products 
that can distort taxonomic distributions and the relative 
frequencies observed in sequencing datasets is frequently 
overlooked.
We recently developed and reported on methods to 
effectively separate mucosal and submucosal intestinal 
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mucosa to that of the subjacent submucosa [8]. Since 
bacterial translocation across the mucosal barrier is a 
prominent feature in Crohn’s disease [9], we sought to 
enumerate the bacterial load within submucosal tissues 
of resected tissues from patients with Crohn’s disease. 
However, the amount of contamination in negative no-
template controls and in standards made quantitative 
determinations unachievable in submucosal samples, pre-
sumably a combination of low bacterial biomass and large 
amounts of competitive human DNA in the samples.
Although largely unappreciated, the scientific literature 
documents widespread microbial DNA contamination of 
PCR reagents and several methods had been proposed 
to eliminate and/or reduce background impurities and 
noise including UV irradiation, restriction endonuclease 
and DNAse digestion, and treatment with ethidium mon-
oazide (EMA) [7, 10, 11], but none of the proposed meth-
ods has proved capable of reliably reducing DNA reagent 
contamination.
Despite reports and alleged common knowledge, rea-
gent contamination apparently remains underappreci-
ated in the microbiota research community. Most DNA 
sequence-based publications describing the microbial 
communities of low-biomass environments do not carry 
out sequencing of negative controls, or do not describe 
their contaminant removal or identification procedures 
[12]. A number of microbiota studies report taxa, often 
statistically noteworthy, that overlap with those reported 
for negative control reagents and water [12–14].
Previous reports dealing with issues of contamina-
tion used hypothetical situations and spiked samples to 
determine the effects of contamination. Herein we report 
on our efforts to determine bacterial loads within sub-
mucosal intestinal tissues and blood and the effects of 
contamination on those efforts. We also report the iden-
tification of bacterial DNA contaminants present in com-
monly used DNA extraction and isolation reagents and 
demonstrate the significant impact they may have upon 
investigations of the microbiota and microbiome.
Methods
Patient populations and samples
Institutional Review Board approval was obtained at all 
cooperating Institutions prior to study initiation. Patients 
with Crohn’s disease and non-inflammatory bowel dis-
ease (non-IBD) controls scheduled for surgical resections 
were recruited from the University of Louisville, Ken-
tucky, and Texas Tech University Health Sciences Center, 
El Paso, and affiliated Hospitals. A 1  cm2 full-thickness 
section of diseased and/or normal intestinal tissue was 
obtained under sterile conditions at the time of surgery. 
Peripheral blood was collected under aseptic conditions 
in PreAnalytiX PAXgene Blood DNA Tubes (Qiagen, 
USA) from each patient either at the time of informed 
consent, during surgical prep, or during surgery. Blood 
and intestinal tissues were obtained from selected 
patients previously reported [8].
DNA isolation kits
The MoBio PowerMax® Soil DNA Isolation Kit 12,988-10 
(MoBio Laboratories, USA) was used for all tissue DNA 
isolations. The moBio Soil DNA isolation kit was chosen 
because it was the extraction method used by the Human 
Microbiome Project.
Because our laboratory uses many of these kits on a 
continuous basis, multiple kits are ordered simultane-
ously (as many as 10 at a time) and often represent sev-
eral lot numbers. Since each component within each 
kit lot has an individual lot number and the individual 
lot numbers often vary within kits of the same lot, and 
because several entire kits were often used in a single 
day and henceforth mixed, no efforts were made to keep 
track of all the various individual lot numbers. DNA was 
extracted from blood collected in PreAnalytiX PAXgene 
Blood DNA Tubes with the PreAnalytiX PAXgene™ 
Blood DNA Kit (Qiagen, USA). As with the MoBio 
Kits, the Blood DNA Kits contained kit lot numbers as 
well as different lot numbers for all the individual kit 
components.
Tissue processing and DNA extraction
Methods employed for the processing of tissues, separa-
tion of mucosal and submucosal tissues, and extraction 
of DNA have previously been described [8]. Briefly, after 
intestinal mucosal and submucosal layers were excised 
and separated, DNA was extracted from mucosal digests 
and submucosal tissue using the MoBio PowerMax Soil 
DNA Isolation Kit employing 100 µm molecular biology 
grade (MBG) Zirconium beads rather than the supplied 
garnet beads, followed by digestion with proteinase K, 
and the use of a high-energy cell disrupter as previously 
described [8].
DNA was extracted from blood using the PreAnalytiX 
PAXgene™ Blood DNA Kit following the manufacturer’s 
protocol. Indigenous DNA contamination was monitored 
by replacing tissue with 1 ml of MBG water and 100 µl 
1  M DL-dithiothreitol, and blood with 5  ml of MBG 
water and processed as above for the respective tissue 
type. All tissue and DNA processing were performed 
under aseptic conditions.
The total amount and purity of DNA present follow-
ing extraction was determined by spectrometry at 260 
and 230  nm in a NanoDrop spectrophotometer. The 
amount of human DNA in samples was determined 
using the Quantifiler® Human DNA Quantification Kit 
(Applied Biosystems) based on the human telomerase 
Page 3 of 12Glassing et al. Gut Pathog  (2016) 8:24 
reverse transcriptase (hTERT) gene per manufacturer’s 
instructions.
16S Microbiota sequencing on the Illumina MiSeq 
platform
Bacterial species and microbial ecology within tis-
sue samples and reagents were detected and identified 
using the 16S universal Eubacterial primers 27Fmod and 
519Rmod in the Illumina MiSeq platform with methods 
based upon the bTEFAP® process [8]. The Q25 sequence 
data derived from the sequencing were processed using 
a standardized analysis pipeline [8]. Operational taxo-
nomic units (OTU’s) were defined after removal of sin-
gleton sequences, clustering at 3  % divergence (97  % 
similarity). Final OTUs were taxonomically classified 
using BLASTn against a curated database derived from 
GreenGenes Version 13.5 (http://www.greengenes.lbl.
gov/cgi-bin/nph-index.cgi), RDPII (http://www.rdp.cme.
msu.edu), and NCBI (http://www.ncbi.nlm.nih.gov) data-
bases (including non-bacterial sequences) and compiled 
into each taxonomic level by both “counts” (actual num-
ber of sequences) and “percentage” (relative proportion 
of sequences within each sample) files.
OTU’s were assigned taxonomic classification based 
on standard algorithms using the following taxonomic 
designation:  >97  % identity was classified at the spe-
cies level; between 97 and 95 % identity was designated 
as an unclassified species; between 95 and 90  % iden-
tity was designated as an unclassified genus; between 
90 and 85  % identity was designated as an unclassified 
family; between 85 and 80 % identity was designated as 
an unclassified order; between 80 and 77 % identity was 
designated as an unclassified phylum. OTU’s that failed 
to match any bacterial sequence at 77 % or above, were 
then blasted against non-bacterial databases to produce 
alignments and identities within the Metazoa, Bacteria, 
Fungi, and Viridiplantae Kingdoms as well as sequences 
classified as Unclassified (less than 77 % match with any 
database sequence).
qPCR
We attempted to quantify the total bacterial load 
within samples (both tissue and reagent) using several 
rRNA gene universal primer sets and probes previously 
described [7, 10, 15, 16]. Real-time quantitative PCR 
was performed using the Applied BioSystems Taqman 
Universal Master Mix in an Applied BioSystems Viia-7 
Real-Time PCR System using 20  µl total reaction mix-
ture in 384-well plates according to the manufacturer’s 
instructions. PCR conditions were 50 °C for 2 min, 95 °C 
for 10 min, and then 40 cycles at 95 °C for 15 s and 60 °C 
for 1  min. The Qiagen QuantiFast Pathogen PCR  +  IC 
Kit was also evaluated according to the manufacturer’s 
instructions. All plates were inoculated with an EpMo-
tions 7075 robotic liquid handling system in 384 well 
plates. Tissue DNA was normalized to 50 ng/µl, based on 
optical density in a Nanodrop spectrophotometer, previ-
ously determined to be an appropriate concentration in 
most qPCR applications [17].
Data were analyzed using the Applied BioSystems 
Viia-7 software. All assays were performed in triplicate 
and included negative controls without patient template 
DNA (no template controls, NTC). A strain of enteroag-
gregative (EAEC) Escherichia coli (strain 042) was used 
as a positive control and as a quantitative standard in all 
assays. No template controls with only MBG water and 
no template were used to detect bacterial DNA in the 
qPCR protocol and reagents.
To eliminate the MGB water as the source of bacterial 
contamination, MGB water used as a negative control in 
all assays was exposed to UV radiation for at least 12 h 
(overnight) prior to use.
Removal of contaminating DNA
Since treatment with DNAse, restriction endonucle-
ase digestion, and UV radiation have in the past proved 
unsuccessful in eliminating background DNA from 
PCR reagents without compromising the subsequent 
PCR reaction [7], we attempted to use ethidium mono-
azide (EMA) treatment of our PCR master mixes, water, 
and reagents as previously described [10, 11, 18]. This 
method had previously been purported to be effective in 
determining bacterial loads in plasma.
Briefly, master mixes, MGB water, and other reagents 
used in the qPCR reaction were treated with various 
concentrations of EMA and exposed to a 500 W halogen 
light at 20  cm distance on ice for various time periods 
to determine the optimal EMA concentrations and light 
exposure times. Optimal EMA concentrations and light 
exposure times were determined for each reagent lot.
Statistical analysis
Statistical analysis was performed using a variety of 
computer packages including XLstat, NCSS 2007, “R” 
(http://www.r-project.org/) and NCSS 2010 as previously 
described [8]. Significance reported for any analysis was 
defined as p < 0.05, corrected for multiple testing using 
ANOVA with Tukey’s HSD (honestly significant differ-
ence) post hoc analysis.
Results
Bacterial quantitation based on 16S rRNA sequencing
We first sought to estimate the amount of human and 
bacterial DNA in each of the samples by comparing the 
alignment of OTU’s to the Bacteria and Metazoan king-
doms. Since it requires 1000 bacterial genomes to equal a 
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single human genome [19], a sample containing an abun-
dance of human DNA would be considered to have a low 
microbial biomass. Although only semi-quantitative [12], 
the number of read counts (fasta hits) and the alignment 
of OTU’s can be indicative of the overall relative abun-
dance of bacteria DNA as well as the amount of compet-
ing human DNA.
Illumina MiSeq  16S rRNA gene sequencing of blood 
generally produced an average of only  ~2000 sequences 
per sample (as opposed to concurrently processed 
mucosal tissues which yielded on average  ~116,000 
sequences). Furthermore, only about 25  % of the gen-
erated OTU’s in blood aligned to the Kingdom Bacte-
ria, with the remainder 75  % aligning with Metazoa, 
suggested a low microbial biomass and high metazoan 
(human) DNA. Similar observations were noted with sub-
mucosal tissues. Where mucosal tissues averaged 116,248 
sequences per sample, the subjacent submucosal sam-
ples (run concurrently) averaged only 15,461 sequences. 
There was also a significant difference in the number of 
sequences aligning to the human genome (p  ≤  0.001) 
between the mucosa and submucosa confirming that sub-
mucosal samples, similarly to blood, had a high human 
DNA relative content and a low microbial biomass.
qPCR using universal rRNA gene primers and probes
In an effort to determine the total bacterial load pre-
sent within peripheral blood and submucosal tissues of 
patients with Crohn’s disease, we evaluated the use of 
qPCR using universal rRNA gene primers and Taqman 
probes. Quantitation, however, generally proved unsuc-
cessful in DNA from blood, submucosal tissues, and 
other low bacterial biomass samples because CT values 
were often equal to or greater than those produced in no 
template controls. No template controls, using irradiated 
MBG water instead of template, typically produced CT 
values averaging 29 (range 26–31).
In an effort to reduce the background effects contami-
nation, we evaluated a variety of different universal prim-
ers and qPCR master mixes. There was no statistically 
significant difference in the level of background microbial 
DNA detected in no template controls (NTC) between 
the different universal rRNA gene primer-probes evalu-
ated; however, the universal primers and probe with 
additional forward primers for Propionibacterium and 
reverse primer for Bacteroides, as previously described 
[10], consistently produced lower CT values and were 
used in most subsequent experiments. There was also 
no significant difference in the level of amplification (CT 
values) in no-template controls using master mixes from 
different manufacturers, even those claimed to have low 
DNA contamination and designed specifically for bacte-
rial DNA quantitation.
Samples containing large amounts of human DNA and 
small amounts of microbial DNA as estimated by fasta 
counts and OTU alignments, such as submucosal tissues 
and blood, produced CT values greater than no template 
controls suggesting that there was less bacteria in the tis-
sue samples than in negative controls (Fig.  1). As such, 
this background precluded bacterial quantitation with 
qPCR using universal primers. This inhibition (CT value 
greater than no template controls) was presumed to be 
the result of competitive inhibition created by the large 
amount of human DNA in the sample [20]. Bacterial 
quantitation could only be achieved in mucosal samples 
which consistently produced CT values less than negative 
template controls allowing the amount of bacterial DNA 
present in the sample to be estimated based on internal 
bacterial standards.
Removal of inherent microbial DNA contamination 
from PCR reagents
Since background contamination precluded bacterial 
quantitation, we sought to remove the background bac-
terial DNA in anticipation that such would allow quan-
titation of submucosal and blood bacterial DNA levels. 
Pre-treatment of master mixes, primers and probes, 
and MBG water (for NTC controls) with pre-optimized 
concentrations of EMA, eliminated or greatly reduced 
background contaminating microbial DNA but caused a 
3–4 cycle downward shift in CT values which adversely 
affected detection, quantitation, as well as reproduc-
ibility and uniformity (standard deviation) of samples. 
Thus, pre-treatment of reagents with EMA was found to 
be ineffective in blood and submucosal samples making 
efforts to eliminate background DNA technically difficult 
and unproductive.
Quantitation of contaminating bacterial DNA
Since qPCR suggested that tissue and blood samples con-
tained less bacterial DNA than negative controls (CT val-
ues greater than no template controls), efforts were made 
to quantify the amount of bacterial DNA in negative con-
trols. Such determinations could allow the quantitation 
of bacterial DNA in tissue samples by using negative con-
trols as standards in quantitation by ΔΔCT.
Spectrophotometric analysis of the PreAnalytiX PAX-
gene™ Blood DNA Kit using MBG water instead of blood 
failed to yield any detectable DNA or the amount of 
DNA detected was negligible (<1 ng/µl). The processing 
of MBG water through the MoBio PowerSoil DNA Isola-
tion Kit typically yielded an optical density (OD) reading 
at 260 nm suggesting 19–25 ng DNA per µl. The 260/280 
OD ratio was, however, always >2.0 and produced a flat-
tened spectral peak suggesting the presence of contami-
nants affecting the absorbance at 260 nm. These findings 
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suggest that OD readings obtained following extraction 
with the MoBio PowerSoil DNA kit may not be accurate 
and may over estimate the amount of DNA in low bio-
mass samples.
To more accurately determine the amount of DNA 
present after processing MBG water through the DNA 
extraction kits, we performed quantitative qPCR using 
serial dilutions of pure microbial DNA derived from E. 
coli. Assuming the complete absence of contamination, 
the copy number of 16S rRNA genes should correlate 
with the dilutions of E. coli and reduce or increase in a 
linear fashion as a standard curve. CT values remained 
stable and did not reduce further at dilutions below 5 
bacterial genomes per µl, indicating the presence of back-
ground DNA at approximately 28–35 rRNA copies per µl 
(4–5 E. coli genomes) in both the Applied Biosystems and 
the Qiagen Master Mixes (Fig.  2). This contamination 
estimate was based on the assumption that there was a 
complete absence of contamination and that the CT val-
ues of standards were not influenced or altered by back-
ground contaminating DNA levels. Thus, the true level 
of DNA contamination would be 28–35 rRNA copies per 
µl + unknown contaminating genomes in the qPCR mas-
ter mix.
Having determined the amount of contamination pre-
sent in negative PCR controls, we could now determine 
the amount of contamination that came from DNA 
extraction kits as opposed to other sources such as PCR 
reagents, laboratory consumables, or lab personnel. 
Processing purified MBG water through the MoBio 
PowerSoil DNA extraction kit followed by qPCR with 
universal bacterial primers, based on calculation of bac-
terial DNA on quantitative E. coli standards and relative 
ΔΔCT, it was estimated that the MoBio PowerSoil DNA 
extraction kit contributed approximately 10–15 E. coli 
equivalent genomes (70–105 rRNA gene copies) per µl of 
template to the qPCR reaction mixture.
Influence of competitive DNA on background DNA levels
The amount of contaminating DNA calculated above 
(Fig. 2) was based on the addition of pure E. coli bacterial 
DNA in MBG-irradiated water and does not consider the 
effects of human or other DNA as a competitive inhibitor 
of the PCR reaction, as would be present in most clinical 
samples [20]. To determine the effect of human DNA on 
sensitivity (competitive inhibition) and obtain more accu-
rate bacterial quantitation, we added 250  ng of human 
peripheral blood DNA (50  ng/µl in 5  µl) and increasing 
amounts of E. coli genomic DNA to ascertain the amount 
of bacterial DNA required to exceed background in the 
presence of an excess amount of human DNA. As done 
previously, assuming a complete absence of contamina-
tion, the CT value corresponding to the number of 16S 
rRNA gene copies present in the sample should correlate 
with dilutions of E. coli and reduce in a linear manner as a 
standard curve.
At 125 E. coli genomes, equivalent to 875 rRNA gene 
copies, the copy number (CT value) remained stable and 
Fig. 1 Contaminating endogenous DNA from DNA extraction and processing kits produced CT values of 28–30 in no template controls using uni-
versal rRNA gene primers. Samples containing low bacterial biomass and high levels of competing human DNA, such as intestinal submucosal or 
peripheral blood samples, often produce CT values greater than the no template controls. Bacteria are discernable from background only in samples 
containing a high bacterial biomass such as intestinal mucosal tissues. Reagent contamination interferes and prevents bacterial quantitation based 
on the rRNA genes in low bacterial biomass samples
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did not reduce further, indicating that approximately 875 
rRNA gene copies (as opposed to 35 rRNA gene cop-
ies in water) were required to overcome the inhibitory 
effects of peripheral blood DNA. These findings support 
the notion that the true amount of contaminating bacte-
rial DNA is far greater than the 4–5 genomes calculated 
based on pure bacterial DNA above. Because the periph-
eral blood DNA did not display any inhibitory effects 
with primers/probes directed against the human genome, 
including the human telomerase reverse transcriptase 
used in DNA quantitation, the inhibition observed is pre-
sumed to result from competitive inhibition created by 
the excess amount of human DNA in the samples.
Diversity of contaminating bacterial DNA
Illumina MiSeq  16S rRNA gene microbiota sequencing 
identified a host of contaminating bacterial taxa within 
qPCR no template controls and DNA extraction kits. 
We identified 88 additional genera that may be found as 
contaminants of commonly used DNA extraction kits, 
bringing the total of known contaminating genera to 181 
(Tables  1, 2; Additional file  1: Table  S1). By sequencing 
negative PCR controls and irradiated-MBG water we are 
able to differentiate what came from DNA extraction kits 
as opposed to other sources including reagents, labora-
tory consumables, or laboratory personnel.
Blood
Sequencing of MBG water that was processed through 
the Qiagen PreAnalytiX PAXgene™ Blood DNA Kit 
and sequencing the end product on the Illumina MiSeq 
platform generated an average of 1209 sequences which 
translated into 44 operational taxonomic units (OTU’s) 
belonging to the Kingdom Bacteria and aligning to 24 
bacterial families, 29 genera and 39 tentative species 
(Table 1). Of the 29 Genera, 13 were present at a relative 
prevalence  >0.1  %. Among the tentative species identi-
fied, Geobacillus thermoparaffinivorans accounted for 
54  % of the relative population, followed by Propioni-
bacterium acnes at 34 %, and Pelomonas spp. at 3 %. The 
remaining 35 species were present at a relative prevalence 
of <1 %, but included many species commonly associated 
with the environment and the gastrointestinal microbiota 
(Additional file 1: Table S1).
Tissue
Sequencing of MBG water processed through the MoBio 
Soil DNA Isolation Kit and sequencing the end product 
on the Illumina MiSeq platform produced an average of 
29,387 sequences, suggesting an abundance of bacterial 
DNA. These sequences formed 1618 OTU’s of which 54 
OTU’s did not align with any known sequence (no hits 
found) within the Kingdoms Metazoa, Bacteria, Fungi 
or Viridiplantae. In total, DNA from 81 bacterial genera 
and 108 tentative species were identified as contaminants 
within this isolation kit (Table 2). Organisms of the gen-
era Propionibacterium spp. (26 %) and Methylobacterium 
spp. (22 %) accounted for almost 50 % of the population, 
although a variety of other organisms were represented 
at relative frequencies >1 %. Of the 108 tentative species 
Fig. 2 Background levels of bacterial genomes based on 16S rRNA gene universal primers suggest a level of at least 4 bacterial genomes per µl of 
qPCR reaction mixture. Although the true amount of contaminating bacterial DNA would be 4 + NTC, assuming the lowest possible figure, a stand-
ard 50 µl qPCR reaction would contain at least 200 E. coli-equivalent genomes or approximately 1400 rRNA gene copies contaminating the reaction
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of bacterial DNA detected, 74 % or 80 species are specifi-
cally associated with and considered normal inhabitants 
of the human gastrointestinal tract and/or the environ-
ment (Additional file 1: Table S1).
Distortion of taxonomic distributions and relative 
frequencies by contaminating bacterial DNA in low 
microbial biomass samples
Peripheral blood
Although the total number of sequences and OTU’s 
generated from blood samples were greater than blood 
blank controls (MBG water processed through the DNA 
extraction/isolation methods), the actual sequence 
Table 1 Bacterial families and genera identified in periph-
eral blood DNA extraction kits processed with  molecular 
biology grade water instead of blood
Bacterial DNA belonging to 29 genera and 39 tentative species were found to 
contaminate peripheral blood DNA extraction kits
See Additional file 1: Table S1 for list of tentative species identification
a Relative percent prevalence are average of multiple lots
b Detection of organism was lot dependent and not present in all lots
Family Genus Relative %a
Actinomycetaceae Actinomyces spp. 0.082576
Bacillaceae Geobacillus spp. 56.39967
Bacteroidaceae Bacteroides spp. 0.743187
Bifidobacteriaceae Bifidobacterium spp.b 0.082576
Carnobacteriaceae Granulicatella spp.b 0.165153
Comamonadaceae Alicycliphilus spp.b 0.082576
Pelomonas spp. 3.220479
Coriobacteriaceae Atopobium spp.b 0.082576
Enterobacteriaceae Escherichia spp. 0.247729
Enterococcaceae Enterococcus spp.b 0.165153
Erysipelotrichaceae Erysipelatoclostridium spp.b 0.082576
[Gemellaceae] Gemella spp.b 0.082576
Lachnospiraceae Blautia spp. 1.156069
Dorea spp. 0.247729
Roseburia spp. 0.247729
Lactobacillaceae Lactobacillus spp.b 0.082576
Microbacteriaceae Agrococcus spp. 0.247729
Oxalobacteraceae Herbaspirillum spp.b 0.082576
Pasteurellaceae Haemophilus spp. 0.495458
Phyllobacteriaceae Phyllobacterium spp.b 0.082576
Porphyromonadaceae Parabacteroides spp.b 0.082576
Propionibacteriaceae Propionibacterium spp. 34.10405
Pseudomonadaceae Pseudomonas spp.b 0.082576
Rhodobacteraceae Ruegeria spp.b 0.082576
Rikenellaceae Alistipes spp.b 0.082576
Streptococcaceae Streptococcus spp. 1.156069
Veillonellaceae Dialister spp. 0.082576
Quinella spp. 0.082576
Veillonella spp. 0.165153
Table 2 Bacterial families and genera identified within the 
MoBio DNA extraction kit DNA from  81 bacterial genera 
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counts (~1000) and OTU’s that corresponded to bacte-
ria were generally equal to or less than blank controls, 
presumably the result of competitive inhibition by large 
excesses of human DNA. The OTU’s that misaligned 
with human DNA represented on average 76  % of all 
generated OTU’s. Although 176 discrete bacterial genera 
were identified within blood samples from patients with 
Crohn’s disease and controls in total, many genera were 
unique to one or more individuals.
The predominant genera found in blood blank controls 
were Geobacillus (~56  %), Propionibacterium (~34  %), 
and Pelomonas (~3 %) with remaining bacteria represent-
ing  <1  % relative prevalence (Table  1). Although rRNA 
genes of Propionibacterium spp. and Pelomonas spp. 
were found in peripheral blood at low relative prevalence 
(~1 and ~0.05  %, respectively), organisms of the genus 
Geobacillus were completely absent in all intestinal tissue 
samples previously examined [8], representing 70 DNA 
samples, and only detected in 3 blood samples. Based on 
the presence of Geobacillus spp. within blood samples, 
the relative prevalence of bacteria in these samples were 
considered to be possibly distorted by contaminating 
DNA from the extraction kit.
Removing bacteria of low prevalence (<0.01 % relative 
prevalence) and in less than 50 % of the patient popula-
tion (~92  % relative prevalence remaining) and then 
removing bacteria identified in blank controls as possi-
ble contamination left only 5 species remaining: Anaero-
stipes spp., Mogibacterium spp., Subdoligranulum spp., 
Halocella spp., and Sphingobium spp. that collectively 
represented less than 1 % relative prevalence in the origi-


































































These taxa are unlikely to have been introduced by PCR kit reagents or 
contamination on the bench, and so are likely to have originated from the DNA 
extraction kit and during the DNA extraction process
See Additional file 1: Table S1 for list of tentative species identification
a Relative percent prevalence are average of multiple lots
b Detection of organism was lot dependent and not present in all lots
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identified as possible contamination in blank controls 
was not a viable solution of dealing with possible con-
tamination issues.
Tissue samples
DNA isolated from submucosal tissues contained sig-
nificantly more sequences that aligned with human 
DNA (similar to blood) than the corresponding DNA 
isolated from the superjacent mucosa (p  ≤  0.001) and 
more closely resembled peripheral blood than intestinal 
mucosal tissues. The generated metazoa:bacteria ratio of 
the submucosal sequences averaged 2.7, similar to blood 
at 3.6 and dissimilar to most mucosal samples which 
averaged 0.003. These findings support the notion that 
DNA extracted from submucosal tissues contains a high 
human DNA content and a low microbial biomass.
The total number of sequences generated, i.e., depth of 
coverage, was not a reliable indicator of bacterial content. 
Although the total number of sequences generated aver-
aged 67,500 per intestinal submucosal sample, the total 
number of sequences that aligned with the Kingdom Bac-
teria was 22,800 (as opposed to 102,655 for the super-
jacent mucosa). This was often less than that of tissue 
extraction blank controls (which averaged 23,845) run 
concurrently.
Determining the effects of microbial contamination 
of reagents on submucosal tissue samples proved more 
problematic than with peripheral blood samples. The 
predominate organisms present in tissue extraction blank 
controls were organisms of the Genera Corynebacterium 
(~2  %), Methylobacterium (~12  %), Prevotella (~10  %), 
Propionibacterium (~16  %), Staphylococcus (~5  %), 
Streptococcus (~13  %), and Tumebacillus (~4  %) which 
represented approximately 70  % relative frequency of 
contaminating DNA from the extraction kits. These and 
most other bacteria present within extraction controls 
are considered normal and common inhabitants of the 
intestinal tract and were detected in most submucosal 
and mucosal tissue samples. As with peripheral blood, 
removal of contaminating genera from submucosal tis-
sue samples resulted in only 5 % of the relative bacterial 
population remaining. Most other organisms within tis-
sue extraction blanks were present in low relative preva-
lence (<0.1  %) and lot dependent. Evaluating the effects 
of contamination in tissue samples required analysis at 
the tentative species level.
Identification at the species level based on rRNA 
gene sequences can only be considered tentative due to 
overlapping rRNA genes between species and the ever-
changing bacterial classification at the species level. Nev-
ertheless, run concurrently, differences at the species 
level can be used to determine whether inherent contam-
ination was likely to have influenced microbial relative 
prevalence within low bacterial biomass samples. How-
ever, each reagent(s) lot needed to be sequenced in addi-
tion to being sequenced concurrently with each sample 
run to compensate for differences in sequencing depth/
coverage.
The stone-dwelling Actinobacteria, Blastococcus sax-
obsidens, was found to be a consistent organism detected 
as contaminating DNA from all tissue extraction control 
blanks and, being aerobic and a having a preferred grow-
ing temperature of 28  °C, is not generally considered a 
normal inhabitant of the gastrointestinal tract. It was not 
detected in 145 mucosal samples or 47 blood samples. It 
was detected in only 6 of 142 submucosal samples. All six 
of the submucosal samples in which B. saxobsidens was 
detected also contained DNA from other unexpected 
bacteria found in blank controls including one or more 
of Arthrobacter psychrolactophilus, Meiothermus spp., 
Methylobacterium radiotolerans, Roseateles depolymer-
ans, and Roseomonas cervicalis. Based on the presence of 
DNA from these species within submucosal tissues, the 
bacterial relative prevalence in these samples were con-
sidered to be possibly distorted by contaminating DNA 
from the extraction kits.
Similarities between DNA extraction Kits
Although there was diversity in the number of genera 
(19–24) and species (78–108) between lots of the MoBio 
DNA Extraction Kit, the predominant 20 bacterial gen-
era (and 20 bacterial species) representing 69  % (range 
65–72  %) of the relative bacterial population were con-
sistently detected in all lots. Diversity in the other 31 % 
(represented in 88 genera and 143 species) were present 
in low prevalence and were lot dependent. Contami-
nants in the Qiagen Blood Kit, although comprising on 
average 29 distinct genera and 39 species, was pre-
dominately composed of Propionibacterium acnes and 
Geobacillus thermoparaffinivorans which collectively 
represented 91 % of the total relative prevalence, 34 and 
57 % respectively.
There were limited similarities in the bacterial con-
taminants detected between the MoBio and Qiagen Kits. 
Although ~16 % (18 genera and species) were randomly 
shared between the 2 kits, these were all lot depend-
ent and, except for Propionibacterium acnes which was 
detected in all kits, none of the predominant bacteria 
were shared between the 2 kits.
Discussion
It has long been documented that reagents, even molec-
ular biology grade used in the isolation and process-
ing of DNA, can be contaminated with bacterial DNA. 
Despite this purported general knowledge and high pro-
file reports of reagent contamination affecting microbial 
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datasets and their interpretation [21–23], few studies 
seem to appreciate the impact such contamination may 
have on microbiota and other microbial analyses and 
subsequent conclusions. Although contamination from 
exogenous or inherent sources may not be a problem in 
samples containing a high microbial load, many envi-
ronmental and human tissue samples have low bacterial 
biomass in relation to the overall sample size and DNA 
content.
As demonstrated herein, inherent contamination pre-
vented the determination of bacterial load within samples 
containing low microbial content such as in human intes-
tinal submucosal and peripheral blood samples. Because 
of background contamination, our threshold of detection 
(CT) using pure bacterial DNA in water was approxi-
mately 10 E. coli equivalent genomes or approximately 
70 rRNA gene copies per µl in the absence of competing 
human DNA. Detection levels were significantly affected 
by the presence of competing human DNA, increasing to 
125 E. coli genomes or 875 rRNA gene copies per µl to 
overcome background contamination.
Salter et al. [12] reported, using spiked Salmonella bon-
gori as template, that at least 1000 S. bongori genomes 
were required to obtain reliable rRNA gene sequences 
and that at template concentrations less than 1000, 
sequences were dominated by the contaminating micro-
bial DNA. This is similar to our findings. These investi-
gators also suggested that the FastDNA Spin Kit for Soil 
(MP Biomedicals, Santa Anna, CA) may contribute as 
many as 500 rRNA gene copies per µl of elusion buffer 
[12]. In contrast, although present, we were unable to 
determine the amount of contaminating DNA in the Qia-
gen Blood Kit and only 10–15 E. coli genome equivalents 
(70–105 rRNA gene copies) per µl elution buffer from 
the MoBio Power Soil DNA Extraction Kit. The FastDNA 
Spin Kit for Soil contained 63 bacterial taxa having a 
relative prevalence >0.1, while we only detected 41 total 
bacterial taxa (16–25 taxa per lot) having a relative prev-
alence  >0.1 in the MoBio Kit (78–108 total taxa) and 
only 17 taxa in the Qiagen Kit (39 total taxa). Thus, the 
amount of contaminating DNA may vary greatly depend-
ing on the manufacturer and the specific DNA extraction 
kit used.
As shown with the MoBio Power Soil DNA Kit, pro-
cessing irradiated MBG water through the kit and check-
ing the DNA elusion by spectrophotometry can give the 
impression that the DNA extraction was successful when 
in fact the DNA that is present and being measured may 
all be contaminating DNA from the extraction kit. When 
dealing with samples containing a low bacterial biomass, 
a single bacterial genome contaminant could greatly alter 
the relative bacterial prevalence within the sample. It is 
worth noting that the MoBio Power Soil DNA Kit was the 
primary DNA extraction method of the Human Microbi-
ome Project [24].
The issue of endogenous bacterial DNA contamina-
tion is not limited to rRNA microbiota sequencing, but 
applies equally to PCR and other genetic determinations. 
We show that a commonly used DNA extraction kit and 
master mix would contribute 200–275 E. coli equivalent 
bacterial genomes (2100–2800 rRNA gene copies) in a 
typical 50 µl qPCR reaction. This level of contamination 
with endogenous bacterial DNA could greatly influence 
results, particularly if the target of a PCR reaction was 
present within the contaminating DNA mixture. As such, 
it is inappropriate to use MBG water as a negative (NTC) 
control in PCR reactions as false positive reactions could 
occur due to microbial contamination from the extrac-
tion kit and/or PCR master mixes. DNA extraction 
blanks using the same extraction kit lots and processing 
reagents need to be used as NTC controls to monitor for 
target sequences within DNA contamination. The use of 
MBG water, the typical control, rather than DNA extrac-
tion blanks could account for the irreproducibility of 
results within and between laboratories [25].
Although workflow for post-sequencing processing 
of data has been suggested and is generally the recom-
mended method used to deal with inherent contamina-
tion in samples with low bacterial content [26], these 
methods rely on discounting low prevalence organisms. 
Discounting low prevalence organisms, however, may be 
erroneous. Microbial community profiling based on 16S 
rRNA genes is fraught with bias created by DNA extrac-
tion methods, competitive DNA (human or otherwise), 
primers used during PCR amplification, the sequenc-
ing platform used, depth of coverage, and bioinformat-
ics [20, 27], to name just a few. Depending on the bias, 
organisms identified as low prevalence could actually 
be of high relative frequency or be the most significant 
microbe in the sample and should not be arbitrarily dis-
carded. It is undisputed that Mycobacterium leprae is the 
causative agent of human leprosy, but organisms of the 
genus Mycobacterium appear within the leprous lesion 
at a relative frequency of 0.0007 % as determined by 16S 
rRNA microbiota sequencing of leprosy skin lesions [28]. 
The relative frequency of M. leprae in paucibacillary 
(tuberculoid) leprosy would be substantially less. Under 
recommendations to discount low prevalence organisms, 
mycobacteria in general (including M. leprae) would be 
erroneously discounted as insignificant. Thus, arbitrar-
ily discarding low prevalence microbes as a means of 
compensating for contamination issues may be seriously 
flawed and prevent the detection of pertinent microbes 
within environmental and tissue samples.
We routinely perform blank DNA extractions (using 
irradiated-MBG water rather than tissue) during each 
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tissue extraction to monitor for both endogenous and 
exogenous contamination. These extraction blanks and 
water blanks are sequenced side by side with samples 
so that contamination can be ruled out as the source 
of unique or unusual findings. However, as noted in 
Tables  1, 2 and supplemental data, most of the con-
taminating bacteria are common environmental organ-
isms and/or associated with the gastrointestinal tract or 
skin. For environmental or tissue samples the problem 
of identifying contaminants requires special attention as 
the contaminants may be taxa that are indistinguishable 
from those genuinely present in the samples. In the sam-
ples examined herein, only Geobacillus thermoparaffini-
vorans in the Qiagen kit and Blastococcus saxobsidens in 
the MoBio kit were the only useful indicators of possible 
contamination.
Conclusions
Laboratories working on bacterial populations need to 
define contaminants present in all extraction kits and 
reagents used in the processing of DNA and make such 
determinations with each lot and with each process-
ing of samples. Extraction blanks need to be used as no 
template and other controls as opposed to unprocessed 
water. Any unusual and/or unexpected findings need 
to be viewed as possible contamination as opposed to 
unique findings. Absent consideration and descriptions 
of methods used to monitor and deal with contamination 
issues, data from tissue and other low microbial biomass 
studies, such as the tissue microbiota [29, 30], must be 
questioned. As noted herein, DNA extraction kits them-
selves may generate more than 20,000 sequences on the 
Illumina MiSeq platform representing more than 81 bac-
terial genera.
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